• Home
  • >
  • Morepen Laboratories Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/morepen-laboratories-ltd.png Logo

Morepen Laboratories Ltd Financial Statement

Morepen Laboratories Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Dec 2023Sep 2023Jun 2023
Revenue398.29384.1371.19
Operating Expense343.52351.5344.3
Net Profit35.219.9215.85
Net Profit Margin8.845.194.27
Earning Per Share0.690.390.31
EBIDTA54.7732.5926.88
Effective Tax Rate21.9522.7321.79

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Morepen Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual1,417.531,546.831,188.06
Operating Expenses Annual1,3381,410.151,069.54
Operating Profit Annual85.67146.98130.58
Interest Annual1.98-7.371.79
Depreciation12.415.6330.28
Net Profit Annual38.68101.6897.09
Tax Annual17.0825.021.42

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Morepen Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning15.841.3913.64
Cash Flow from Operations-91.17-60.2450.83
Cash Flow from Investing-46.51-31.68-70.35
Cash Flow from Financing143.5466.3347.27
Cash Flow at the End21.6715.841.39

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Morepen Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)6.049.510.99
PBIT Margin (%)4.077.728.44
PBT Margin (%)1.898.843.4
Net PROFIT Margin (%)3.456.978.47
Return On Networth / Equity (%)5.8120.2725.85
Return On Networth /Employed(%)8.0221.720.94
Return On Assets (%)6.819.6622.03
Total Debt / Equity(X)0.030.030.21
Asset Turnover Ratio (%)1.972.822.6

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Morepen Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual266.97251.8224.52
Total Current Assets Annual756.16734.3526.79
Non Current Assets Annual354.33335.75331.36
Total Shareholders Funds Annual752.91578.56424.75
Total Assets Annual1,110.51,070.05858.15

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Morepen Laboratories Ltd Earning Calls
Dec 2023
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Morepen Laboratories Ltd has a market capitalization of 1,312.68 Cr. Value Research classifies it as a Small-Cap company.

Yes, Morepen Laboratories Ltd is debt-free with a debt-to-equity ratio of 0.03.

In FY 2023, Morepen Laboratories Ltd recorded a total revenue of approximately 1,417.53 Cr marking a significant milestone in the company's financial performance.

Morepen Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.0% and 0.1% annually, respectively..

Morepen Laboratories Ltd's current PE ratio is 33.94.

Morepen Laboratories Ltd's ROCE averaged 16.6% from the FY ending March 2021 to 2023, with a median of 19.9%. It peaked at 22.5% in March 2021, reflecting strong capital efficiency over the period..

Morepen Laboratories Ltd's latest EBIT is Rs. 57.74 Cr, surpassing the average EBIT of Rs. 92.46 Cr over the 5 years..